LEOMINSTER, MA, Mar. 12, 2020—Oligo Factory and Landrau Scientific Innovations have agreed to collaborate on developing a Poly dT affinity purification media. This media will be useful to researchers and process purification laboratories involved in the purification of mRNA-based cancer immunotherapies and infectious disease vaccines. The companies hope that the affinity media will offer an alternative to current methodologies and augment the efforts to fight the spread of infectious diseases like the Coronavirus (Covid-19).

The purification media will provide high flow, low pressure characteristics which easily adapt to current column style purification methods. The affinity aspect insures the highest level of purification. The affinity method leverages the attraction of the poly dA tail, common in mRNA, to the  Poly dT ligand covalently bound to the media.